This medical technology company supplies single-use devices for critical care and surgery to hospitals and healthcare providers worldwide.

Teleflex's TFX robust performance in the Interventional product line is poised to help it grow in the upcoming quarters. The Urolift system is seeing consistent growth in hospitals, with positive ...

Teleflex’s TFX Interventional Urology portfolio is well positioned for sustained growth, led by UroLift’s expanding global footprint and strong clinical differentiation. Supported by favorable ...

Teleflex's (NYSE: TFX) fourth-quarter 2024 earnings conference call, held on February 27, 2025, revealed significant strategic shifts for the medical device company. In a transformative announcement, ...

The stock's fall snapped a four-day winning streak.

Teleflex (NYSE:TFX – Free Report) had its price objective lowered by Mizuho from $150.00 to $130.00 in a research report released on Wednesday,Benzinga reports. The brokerage currently has a neutral ...

On August 1, Teleflex will release earnings for the most recent quarter. Analysts on Wall Street expect Teleflex will release earnings per share of $3.33. Track Teleflex stock price in real-time on ...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where Teleflex Incorporated (NYSE:TFX) ranks among the list of stocks with ...

Teleflex (NYSE:TFX – Get Free Report) was downgraded by research analysts at Raymond James from an “outperform” rating to a “market perform” rating in a report released on Friday, Marketbeat reports.

This was the stock's second consecutive day of losses.